Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
60-Word AI Digest
Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials. Reporting by TechCrunch highlights major developments in this space as key stakeholders evaluate broader implications. Further data and contextual analysis are actively being published. Access the full coverage dispatch below for complete documentation.
Key Takeaways
- Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
- Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
- Click full coverage link below for the complete official dispatch.
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
Original Publisher Attribution
This summary was curated from TechCrunch.